AARTI PHARMALABS LIMITED (AARTIPHARM)

NSE: ₹643.75
BSE: ₹643.65
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 458.36 439.80 448.69 505.77 555.49 458.03 537.78 563.78 386.19 418.33 432.27 582.64
YOY Revenue Growth % - - - 4.27% 21.19% 4.14% 19.86% 11.47% -30.48% -8.67% -19.62% 3.35%
Other Income 0.48 0.98 1.39 2.03 2.22 4.48 5.03 -1.61 1.60 0.05 -0.37 8.05
Total Income 458.84 440.78 450.08 507.80 557.71 462.51 542.81 562.17 387.79 418.39 431.90 590.70
Total Expenses + 394.86 373.83 376.26 412.05 484.03 390.74 442.18 447.55 320.54 379.05 371.16 514.53
Cost of Materials Consumed 220.07 221.89 214.96 201.52 219.81 220.58 261.19 185.45 191.42 203.46 209.42 225.76
Employee Benefit Expense 33.25 31.60 36.16 37.40 39.23 37.73 41.63 43.37 41.26 43.41 43.38 45.05
Other Expenses 69.32 67.95 72.43 97.73 81.56 91.05 92.23 96.03 80.29 90.43 113.93 141.44
Operating Profit 63.50 65.97 72.43 93.72 71.46 67.28 95.60 116.23 65.66 39.28 61.11 68.11
OPM % 13.9% 15% 16.1% 18.5% 12.9% 14.7% 17.8% 20.6% 17% 9.4% 14.1% 11.7%
Profit Before Tax + 63.98 66.95 73.82 95.75 73.68 71.77 100.63 114.62 67.25 39.33 57.95 76.17
Tax Expense 16.89 15.15 21.06 30.50 18.22 17.15 26.64 26.28 17.75 11.41 9.99 15.04
Tax % 26.4% 22.6% 28.5% 31.9% 24.7% 23.9% 26.5% 22.9% 26.4% 29% 17.2% 19.7%
Profit After Tax 47.09 51.80 52.76 65.25 55.45 54.62 73.99 88.34 49.50 27.92 47.96 61.12
EPS (Basic) 5.20 5.72 5.82 7.20 6.12 6.03 8.16 9.75 5.46 3.08 5.29 6.74

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023
Revenue from Operations 1,819.44 2,115.07 1,852.61 1,945.23
YOY Revenue Growth % -13.98% 14.17% -4.76% -
Other Income 9.75 10.12 4.90 2.32
Total Income 1,829.19 2,125.19 1,857.50 1,947.55
Total Expenses + 1,601.47 1,764.50 1,557.01 1,686.78
Cost of Materials Consumed 830.06 887.02 858.45 1,014.30
Employee Benefit Expense 173.09 161.96 138.41 129.69
Other Expenses 442.31 360.87 307.44 303.74
Operating Profit 217.97 350.57 295.60 258.45
OPM % 12% 16.6% 16% 13.3%
Profit Before Exceptional 227.72 360.69 300.49 260.77
Exceptional Items -2.79 0.00 0.00 0.00
Profit Before Tax + 224.92 360.69 300.49 260.77
Tax Expense 50.22 88.28 83.59 67.28
Tax % 22.3% 24.5% 27.8% 25.8%
Profit After Tax 174.71 272.40 216.90 193.49
EPS (Basic) 19.27 30.06 23.93 21.35

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023
ASSETS
Non-Current Assets + 2,084.41 1,584.24 1,236.46 1,075.17
Property, Plant & Equipment 1,335.92 1,104.12 1,014.69 922.74
Capital Work in Progress 305.21 306.58 78.50 62.20
Non-Current Investments 193.85 29.24 0.00 35.52
Goodwill 0.00 1.78 1.78 1.78
Other Intangible Assets 36.01 30.67 16.85 1.32
Current Assets + 1,397.29 1,322.17 1,345.64 1,155.76
Inventories 640.31 587.58 642.86 602.04
Trade Receivables 583.32 575.40 519.34 440.05
Cash and Cash Equivalents 8.53 6.73 23.63 24.93
Current Investments 0.00 47.56 70.39 38.18
LIABILITIES & EQUITY
Total Equity 2,124.60 1,989.91 1,757.04 1,558.48
Equity Share Capital 45.33 45.32 45.31 45.31
Other Equity 2,079.28 1,944.59 1,711.73 1,513.17
Non-Current Liabilities 419.53 259.45 130.68 80.87
Current Liabilities 937.57 657.05 694.38 591.58
Total Liabilities 1,357.10 916.50 825.06 672.45

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023
Cash from Operating Activities 261.93 331.56 216.36 263.00
Cash from Investing Activities -430.72 -413.90 -214.57 -157.80
Cash from Financing Activities 170.58 65.44 9.72 -163.47
Net Increase/Decrease in Cash 1.80 -16.90 11.51 -58.27